重复远程缺血预处理对间歇性跛行患者动脉僵硬度、器官损伤与氧化应激的影响:一项假对照随机试验
本单中心、随机、假对照、双盲先导试验将42例Fontaine IIa/IIb期间歇性跛行男性按1:1分配接受28天远程缺血预处理(RIPC)或假治疗,分析41例(RIPC 23例、假治疗18例)。结果显示两组在动脉僵硬度、心脏、肾脏及氧化应激生物标志物方面均无统计学显著差异。作者认为RIPC未显著改变上述指标,并推测跛行腿本身的反复缺血可能已产生类似预处理效应。
要点
- RIPC组与假治疗组cf-PWV变化中位数均为0.2 m/s(p=.54),无显著差异。
- RIPC组hs-TnT变化中位数0 ng/L vs 假治疗组1 ng/L(p=.54)。
- RIPC组NT-proBNP变化中位数-7 ng/L vs 假治疗组6 ng/L(p=.14)。
核心结论
- 重复RIPC与假治疗相比未显著改变间歇性跛行患者的动脉僵硬度、器官损伤或氧化应激生物标志物。
- 作者推测跛行腿的反复缺血可能已产生类似RIPC的效应,从而削弱手臂RIPC的额外作用。
研究设计与样本
- 单中心、随机、假对照、双盲先导试验,为一项随机对照试验的子研究(ClinicalTrials.gov ID NCT05084066)。
- 42例Fontaine IIa或IIb期间歇性跛行男性按1:1分配至RIPC或假治疗,使用自动化设备在门诊设置下进行28天干预。
- 最终分析41例(RIPC n=23,假治疗 n=18),年龄64.9 ± 7.4岁。
主要发现
- cf-PWV变化中位数:RIPC组0.2 m/s(IQR -0.6, 0.6)vs 假治疗组0.2 m/s(IQR -0.3, 0.8)(p=.54)。
- hs-TnT变化中位数:RIPC组0 ng/L(IQR -1, 2)vs 假治疗组1 ng/L(IQR -1, 2)(p=.54)。
- NT-proBNP变化中位数:RIPC组-7 ng/L(IQR -32, 18)vs 假治疗组6 ng/L(IQR -14, 35)(p=.14)。
- 动脉僵硬度、氧化应激及肾脏生物标志物在两组间均无统计学显著差异。
关键数值与推荐
- 次要结局包括AIx、心率校正AIx、cf-PWV,以及心脏(hs-TnT、NT-proBNP)、肾脏(肌酐、尿素、胱抑素C、β2微球蛋白、NGAL、KIM-1)和氧化应激(hs-CRP、IL-6、IL-18、MPO、脂联素、ox-LDL)生物标志物。
- 干预为使用自动化设备进行28天RIPC或假治疗,门诊设置。
临床怎么用
- 本先导研究未显示28天RIPC较假治疗改善间歇性跛行患者的动脉僵硬度、器官损伤或氧化应激标志物。
- 作者提出跛行腿反复缺血可能已产生类似预处理效应,后续研究设计需考虑这一可能。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The clinical efficacy of remote ischaemic preconditioning (RIPC) remains unclear. This pilot study, a substudy of a randomised controlled trial, tested whether repeated RIPC reduces arterial stiffness, end organ damage, and oxidative stress in patients with intermittent claudication (IC). METHODS: In a single centre, randomised, sham controlled, double blind trial, 42 males with Fontaine stage IIa or IIb IC were allocated at a ratio of 1:1 to receive RIPC or sham using an automated device for 28 days in an outpatient setting (ClinicalTrials.gov ID NCT05084066). Secondary outcomes included changes in augmentation index (AIx), heart rate corrected AIx, carotid-femoral pulse wave velocity (cf-PWV), and biomarkers for cardiac (high sensitivity troponin T [hs-TnT], N-terminal pro B-type natriuretic peptide [NT-proBNP]), renal (creatinine, urea, cystatin C, β2 microglobulin, neutrophil gelatinase associated lipocalin, kidney injury molecule 1), and oxidative stress (high sensitivity C reactive protein, interleukin-6, interleukin-18, myeloperoxidase, adiponectin, oxidised low density lipoprotein). RESULTS: Data from 41 patients (RIPC n = 23, sham n = 18) aged 64.9 ± 7.4 years were analysed. The median change in cf-PWV was 0.2 m/s (interquartile range [IQR] -0.6, 0.6) in the RIPC group vs. 0.2 m/s (IQR -0.3, 0.8) in the sham group (p = .54). The median change in hs-TnT was 0 ng/L (IQR -1, 2) in the RIPC group vs. 1 ng/L (IQR -1, 2) in the sham group (p = .54). NT-proBNP showed a median change of -7 ng/L (IQR -32, 18) in the RIPC group vs. 6 ng/L (IQR -14, 35) in the sham group (p = .14). No statistically significant differences were observed between groups for arterial stiffness, oxidative stress, or renal biomarkers. CONCLUSION: Repeated RIPC did not significantly alter arterial stiffness, end organ damage, or oxidative stress biomarkers compared with sham treatment. It is possible that patients with IC already experience repeated RIPC from their ischaemic legs, thereby attenuating any additional effects from arm induced RIPC.
引用
- Eerik K, Kasepalu T, Post H, et al. Effects of Repeated Remote Ischaemic Preconditioning on Arterial Stiffness, Organ Damage, and Oxidative Stress in Patients with Intermittent Claudication: A Sham Controlled Randomised Trial. Eur J Vasc Endovasc Surg. 2025. PMID: 40571146. doi:10.1016/j.ejvs.2025.06.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。